Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 06, 2016Ranee Mehra, MD : The therapeutic implications of EML4/ALK, ROS-1 and other actionable biomarkersWebcast: 21st Annual Perspectives in Lung Cancer23 minPlay
December 06, 2016Evan W. Alley, MD, PhD : Targeting HER2, BRAF, KRAS, MET, TRKWebcast: 21st Annual Perspectives in Lung Cancer23 minPlay
December 06, 2016Shakun M. Malik, MD: Novel protocol designs in an era of personalized therapyWebcast: 21st Annual Perspectives in Lung Cancer22 minPlay
December 06, 2016Benjamin Levy, MD: Will "liquid biopsy" replace conventional tissue-based sampling?Webcast: 21st Annual Perspectives in Lung Cancer23 minPlay
December 06, 2016Anil Vachani, MD, MS: Lung cancer screening: Impact of the National Lung Screening TrialWebcast: 21st Annual Perspectives in Lung Cancer21 minPlay
December 06, 2016Anil Vachani, MD, MS: When and how to intervene on the growing pulmonary noduleWebcast: 21st Annual Perspectives in Lung Cancer20 minPlay
December 06, 2016Harvey I. Pass, MD: Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - SurgeryWebcast: 21st Annual Perspectives in Lung Cancer20 minPlay
December 06, 2016Charles B. Simone, II, MD: Debate: Surgery versus stereotactic body radiation therapy in early stage NSCLC - SBRTWebcast: 21st Annual Perspectives in Lung Cancer25 minPlay
December 06, 2016Tracey L. Evans, MD: Adjuvant therapy in NSCLC: is there any hope beyond chemotherapy?Webcast: 21st Annual Perspectives in Lung Cancer21 minPlay
December 06, 2016Charu Aggarwal, MD, MPH: Attempts to integrate novel targeted agents and immunotherapy into the combined modality paradigmWebcast: 21st Annual Perspectives in Lung Cancer20 minPlay